These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 28728094

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY, Lim SS, Wallace AL, Vos T.
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [Abstract] [Full Text] [Related]

  • 24. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MP.
    Value Health; 2005 Aug; 8(3):178-90. PubMed ID: 15877590
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
    Mahmoudi M, Coleman CI, Sobieraj DM.
    Int J Clin Pract; 2012 Feb; 66(2):171-82. PubMed ID: 22257042
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.
    Huber MB, Präger M, Coyle K, Coyle D, Lester-George A, Trapero-Bertran M, Nemeth B, Cheung KL, Stark R, Vogl M, Pokhrel S, Leidl R.
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):52-64. PubMed ID: 29243347
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M, Perriot J, Peiffer G, Harika-Germaneau G, Jaafari N.
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea.
    Bae JY, Kim CH, Lee EK.
    Value Health; 2009 Sep; 12 Suppl 3():S70-3. PubMed ID: 20586986
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Drugs for smoking cessation.
    Med Lett Drugs Ther; 2019 Jul 15; 61(1576):105-110. PubMed ID: 31381546
    [No Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of extended cessation treatment for older smokers.
    Barnett PG, Wong W, Jeffers A, Munoz R, Humfleet G, Hall S.
    Addiction; 2014 Feb 15; 109(2):314-22. PubMed ID: 24329972
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun 15; 9(3):215-21. PubMed ID: 19527093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.